Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases

Table 1

Circulating sLOX-1 levels in acute coronary syndrome.

Disease condition	Median (range); P values	Reference
ACS; Non-ACS	2.91 (<0.5–170) ng/mL; 𝑃<0.05 versus all groups; Intact coronary <0.5 (<0.5–1.3) ng/mL; Controlled CHD <0.5 (<0.5–3.4) ng/mL; Ischemic CHD 0.73 (<0.5–14.0) ng/mL	[13]
ACS; Stable CAD; ACS	1.61 (0.941–2.264) ng/mL; 𝑃<0.01 versus stable CAD; 0.579 (0.265–1.172) ng/mL; No complex lesion: 1.003 (0.783–1.668) ng/mL; One-complex lesion: 1.456 (0.923–2.124) ng/mL; Multicomplex lesion: 2.171 (1.067–3.247) ng/mL	[14]
ACS + PCI	Re-ACS: 6.60 ng/mL; 𝑃=0.0024; Event-free: 2.54 ng/mL	[16]
ACS with plaque rupture; ACS w/o plaque rupture; SAP	𝑃<0.001 versus ACS w/o plaque rupture and SAP; 𝑃=0.002 versus SAP	[17]
ACS; Non-ACS	1.13 ng/mL; 𝑃<0.0001; 0.096 ng/mL	[18]
STEMI; NSTEMI; Non-AMI	241.0 pg/mL; 𝑃<0.001 versus NSTEMI; 𝑃=0.001 versus non-AMI; 147.3 pg/mL; 𝑃<0.001 versus non-AMI; 64.3 pg/mL	[19]
AAD; NSTEACS; Control	𝑃<0.001 versus NSTEACS; 𝑃<0.001 versus control; 𝑃<0.001 versus control	[23]

ACS: acute coronary syndrome; CAD: coronary artery disease; PCI: percutaneous coronary intervention; SAP: stable angina pectoris; STEMI: ST elevation myocardial infarction; NSTEMI: non-ST elevation myocardial infarction; AMI: acute myocardial infarction; AAD: acute aortic dissection; NSTEACS: non-ST elevation acute coronary syndrome.